Eli Lilly added additional affordability options for patients with diabetes who use certain insulin products.
What execs and experts think of the future of drug costs.
Authorized generics have been gaining popularity with pharmaceutical manufacturers, but just how do they impact pharmacies?
A cure and a bargain?
Caring for patients requires a successful business.
Update: ASHP statement released.
Programs increasingly cater to the uninsured and underinsured
A record number of new oncology treatments launched in the US last year and spending on cancer drugs soared. Here are the top 6 cancer drug trends revealed in the report.
While pharmacy benefit managers were grilled about insulin prices at Congressional hearings last week, some PBMs, insurers and pharma makers are already lowering insulin costs.
The real-world strategies used to manage the high cost of specialty meds.